Hot Features
プレミアム
UroGen Pharma Ltd (0XOD)
LSE
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | Dr. Mark P. SchoenbergChief Medical Officer | -10.00k | 350.10k | Automatic Disposition | 35.01 | 129.76k | -7.15% |
| 2026-06-08 | Dr. Mark P. SchoenbergChief Medical Officer | 4.78k | 0.00 | Derivative Exercise and Retained Stock | - | 139.76k | 3.54% |
| 2026-06-08 | Dr. Mark P. SchoenbergChief Medical Officer | -5.22k | 142.56k | Derivative Exercise and Sale | 27.30 | 139.76k | - |
| 2026-05-26 | Mr. James A. RobinsonIndependent Director | 2.00k | 0.00 | Derivative Exercise and Retained Stock | - | 6.00k | 50.00% |
| 2026-05-08 | Dr. Mark P. SchoenbergChief Medical Officer | -10.00k | 300.00k | Automatic Disposition | 30.00 | 134.99k | -6.90% |
| 2025-02-26 | Mr. James A. RobinsonIndependent Director | 2.00k | 0.00 | Derivative Exercise and Retained Stock | - | 4.00k | 100.00% |
| 2026-01-31 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | 8.02k | 0.00 | Derivative Exercise and Retained Stock | - | 55.59k | 16.86% |
| 2026-01-31 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -7.48k | 147.26k | Derivative Exercise and Sale | 19.69 | 55.59k | - |
| 2026-02-03 | Dr. Mark P. SchoenbergChief Medical Officer | -7.37k | 145.17k | 売り | 19.69 | 144.99k | -4.84% |
| 2026-01-31 | Dr. Mark P. SchoenbergChief Medical Officer | 13.33k | 0.00 | Derivative Exercise and Retained Stock | - | 142.36k | 10.33% |
| 2025-11-26 | Dr. Stuart HoldenIndependent Director | 2.00k | 0.00 | Derivative Exercise and Retained Stock | - | 2.00k | - |
| 2025-11-26 | Ms. Cynthia Marie ButittaIndependent Director | 2.00k | 0.00 | Derivative Exercise and Retained Stock | - | 2.00k | - |
| 2025-11-26 | Mr. James A. RobinsonIndependent Director | 2.00k | 0.00 | Derivative Exercise and Retained Stock | - | 2.00k | - |
| 2025-11-26 | Dr. Leana S. WenIndependent Director | 2.00k | 0.00 | Derivative Exercise and Retained Stock | - | 2.00k | - |
| 2025-11-26 | Mr. Daniel G. WildmanIndependent Director | 2.00k | 0.00 | Derivative Exercise and Retained Stock | - | 2.00k | - |
| 2025-11-19 | Dr. Mark P. SchoenbergChief Medical Officer | -10.00k | 250.00k | Automatic Disposition | 25.00 | 139.03k | -6.71% |
| 2025-10-08 | Mr. Christopher DegnanCFO | 2.28k | 0.00 | Derivative Exercise and Retained Stock | - | 2.28k | - |
| 2025-10-08 | Mr. Christopher DegnanCFO | -2.20k | 37.12k | Derivative Exercise and Sale | 16.85 | 2.28k | - |
| 2025-09-07 | Dr. Mark P. SchoenbergChief Medical Officer | 796.00 | 0.00 | Derivative Exercise and Retained Stock | - | 149.03k | 0.54% |
| 2025-09-07 | Dr. Mark P. SchoenbergChief Medical Officer | -871.00 | 16.64k | Derivative Exercise and Sale | 19.11 | 149.03k | - |
| 2025-09-07 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | 1.81k | 0.00 | Derivative Exercise and Retained Stock | - | 43.31k | 4.37% |
| 2025-09-07 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -1.52k | 29.05k | Derivative Exercise and Sale | 19.11 | 43.31k | - |
| 2025-08-11 | Dr. Mark P. SchoenbergChief Medical Officer | -10.00k | 176.90k | 売り | 17.69 | 148.23k | -6.32% |
| 2025-07-28 | Mr. Jason Drew SmithGeneral Counsel, CCO & Corporate Secretary | -7.52k | 143.97k | 売り | 19.14 | 41.49k | -15.35% |
| 2025-07-28 | Dr. Mark P. SchoenbergChief Medical Officer | 4.85k | 0.00 | Derivative Exercise and Retained Stock | - | 158.23k | 3.16% |
| 2025-07-28 | Dr. Mark P. SchoenbergChief Medical Officer | -5.15k | 98.55k | Derivative Exercise and Sale | 19.14 | 158.23k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
